Investigation on the Efficacy of 0.1% Tazarotene Gel in Treatment of Patients with Acne Vulgaris
Zhihua Wu
Abstract
Zhihua Wu
Abstract
Objective:To observe the clinical efficacy and safety of 0.1% tazarotene gel short-contact therapy adopted in treatment of mild or moderate facial acne. Methods:A randomized, parallel controlled clinical study was conducted. The patients were treated topically with trial drug, twice-daily (morning and evening) for 12 weeks. Results:Results showed that the effective rates were 24%,40%,60% and 68% respectively in study group at 2,4,8 and 12 weeks. In control group, the effective rates were 19.2% (P=0.631, compared to the study group), 23.1% (P=0.175), 30.8% (P=0.034) and 30.8% (P=0.008) respectively. Conclusion:Short-contact treatment of 0.1% tazarotene gel for mild to moderate facial acne was effective, safe and well tolerated.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy and safety of 0.1% tazarotene gel short-contact therapy adopted in treatment of mild or moderate facial acne. Methods:A randomized, parallel controlled clinical study was conducted. The patients were treated topically with trial drug, twice-daily (morning and evening) for 12 weeks. Results:Results showed that the effective rates were 24%,40%,60% and 68% respectively in study group at 2,4,8 and 12 weeks. In control group, the effective rates were 19.2% (P=0.631, compared to the study group), 23.1% (P=0.175), 30.8% (P=0.034) and 30.8% (P=0.008) respectively. Conclusion:Short-contact treatment of 0.1% tazarotene gel for mild to moderate facial acne was effective, safe and well tolerated.
Key concepts: Tazarotene, Acne, Medicine, Evening, Morning, Dermatology, Clinical efficacy, Clinical trial